Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed CFO
Quarterly results
CFO resigned
CC transcript
Appointed director

OSIRIS THERAPEUTICS, INC. (OSIR) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/17/2019 GN Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc
03/14/2019 GN OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
02/28/2019 GN Predictive Technology Group Names Jay M. Moyes to Its Board of Directors
11/26/2018 GN Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer
11/07/2018 GN Osiris Therapeutics, Inc Reports Third Quarter 2018 Results
10/30/2018 GN Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada
10/02/2018 GN Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living Tissues is an Alternative to Cryopreservation with the Convenience of Ambient Storage
09/17/2018 GN Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018
03/10/2017 GN Osiris Receives Notice of Delisting from NASDAQ
02/10/2017 GN Osiris Appoints Uwe Sommer and Thomas Knapp to its Board of Directors

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy